Drugs that contain Elagolix Sodium,estradiol,norethindrone Acetate; Elagolix Sodium

1. List of Oriahnn (copackaged) drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US7419983 ABBVIE INC Gonadotropin-releasing hormone receptor antagonists and methods related thereto
Jul, 2024

(1 year, 1 month from now)

US7056927 ABBVIE INC Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
Sep, 2024

(1 year, 3 months from now)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US11459305 ABBVIE INC Processes for the preparation of uracil derivatives
Nov, 2028

(5 years from now)

US10881659 ABBVIE INC Methods of treating heavy menstrual bleeding
Mar, 2034

(10 years from now)

US11045470 ABBVIE INC Methods of treating heavy menstrual bleeding
Mar, 2034

(10 years from now)

Do you want to check out ORIAHNN (COPACKAGED) patents from before 2022?
Exclusivity Exclusivity Expiration
New Chemical Entity Exclusivity (NCE) Jul 23, 2023
New Product (NP) May 29, 2023

NCE-1 date: 2022-07-23

Market Authorisation Date: 29 May, 2020

Treatment: Management of heavy menstrual bleeding associated with uterine leiomyomas (fibroids)

Dosage: CAPSULE;ORAL

More Information on Dosage

ORIAHNN (COPACKAGED) family patents

23

United States

3

New Zealand

3

Japan

3

European Union

2

Canada

1

Australia

EA

1

EA

1

Israel

1

Croatia

1

Korea, Republic of

1

Denmark

1

Spain

1

Austria

1

Cyprus

1

Portugal

1

Poland

1

Norway

1

Germany

1

Slovenia

1

Mexico

1

Brazil

1

China

1

South Africa

2. List of Oriahnn (copackaged) drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US11542239 ABBVIE Elagolix sodium compositions and processes
Jul, 2039

(16 years from now)

Do you want to check out ORIAHNN (COPACKAGED) patents from before 2022?
Exclusivity Exclusivity Expiration
New Chemical Entity Exclusivity (NCE) Jul 23, 2023
New Product (NP) May 29, 2023

NCE-1 date: 2022-07-23

Market Authorisation Date: 29 May, 2020

Treatment: NA

Dosage: CAPSULE;ORAL

More Information on Dosage

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic